The lawsuit was filed by Della Wise on behalf of her aunt, Mattie Edgin, who died after taking Xarelto. Wise claims that Xarelto was “fervently marketed … with no regard to the accuracy and misrepresentations of their misleading marketing.”
She cited a study from the Institute for Safe Medicine Practices (ISMP) linking Xarelto to 356 adverse events. In 2013, at least 72 deaths in Germany were also linked to Xarelto.
Wise accuses drug-makers of falsely claiming that Xarelto patients do not need routine tests for bleeding and/or blood clots. She also stresses that Xarelto does not have an antidote — unlike warfarin, which can be reversed with a dose of Vitamin K in a bleeding emergency.
The complaint states:
“Due to the flawed formulation of Xarelto, which according to defendants does not require regular blood monitoring or frequent doctor follow-up, raises concerns about the risk of stroke, bleeding, and blood clots if not taken properly or absorbed properly, particularly in patients with poor renal function.”
The wrongful death lawsuit was filed in the Court of Common Pleas in Philadelphia. Wise is seeking compensation for punitive damages, including fraud, wrongful death, consumer law violations, negligence, failure to warn, product liability, unreasonable marketing of a dangerous drug, and breach of warranty.
Do I have a Xarelto Lawsuit?
The Schmidt Firm, PLLC is currently accepting Xarelto induced injury cases in all 50 states. If you or somebody you know has been injured, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.